MarkerDB 2.0: a comprehensive molecular biomarker database for 2025
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkae1056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Hayley Jackson und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Alberta, Edmonton, ABT6G 2E9, Canada. Hauptthemen laut MEDLINE: Biomarkers. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Genome Alberta, Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
MarkerDB (https://markerdb.ca) has become a leading resource for comprehensive information on molecular biomarkers. Over the past 3 years, the database has evolved significantly, reflecting the dynamic landscape of biomarker research and increasing demands from its user community. This year’s update, which is called MarkerDB 2.0, introduces key improvements to enhance the database’s usability, consistency and the range of biomarkers covered. These improvements include (i) the addition of thousands of new biomarkers and associated health conditions, (ii) the inclusion of many new biomarker types and categories, (iii) upgraded searches and data filtering functionalities, (iv) new features for exploring and understanding biomarker panels and (v) significantly expanded and improved descriptions. These upgrades, along with numerous minor improvements in content, interface, layout and overall website performance, have greatly enhanced MarkerDB’s usability and capacity to facilitate biomarker interpretation across various research domains. MarkerDB remains committed to providing a free, publicly accessible platform for consolidated information on a wide range of molecular (protein, genetic, chromosomal and chemical/small molecule) biomarkers, covering diagnostic, prognostic, risk, monitoring, safety and response-related biomarkers. We are confident that these upgrades and updates will improve MarkerDB’s user friendliness, increase its utility and greatly expand its potential applications to many other areas of clinical medicine and biomedical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of Alberta, Edmonton, ABT6G 2E9, Canada.
- Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, ABT6G 2E9, Canada.
- Department of Computing Science, University of Alberta, Edmonton, ABT6G 2E9, Canada.
- Department of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, ABT6G 2E9, Canada.
ORCID-Profile: David S Wishart
Förderung
- Genome Alberta
- Canada Foundation for Innovation
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Jackson, H., Oler, E., Torres-Calzada, C., Kruger, R., Hira, A. S., López-Hernández, Y., Pandit, D., Wang, J., Yang, K., Fatokun, O., Berjanskii, M., MacKay, S., Sajed, T., Han, S., Woudstra, R., Sykes, G., Poelzer, J., Sivakumaran, A., Gautam, V., …, & Wishart, D. S. (2025). MarkerDB 2.0: a comprehensive molecular biomarker database for 2025. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae1056
Vancouver
Jackson H, Oler E, Torres-Calzada C, Kruger R, Hira AS, López-Hernández Y, et al. MarkerDB 2.0: a comprehensive molecular biomarker database for 2025. Nucleic Acids Research. 2025. doi:10.1093/nar/gkae1056
BibTeX
@article{Jackson2025,
author = {Jackson, Hayley and Oler, Eponine and Torres-Calzada, Claudia and Kruger, Ray and Hira, Amandeep Singh and López-Hernández, Yamilé and Pandit, Devanshi and Wang, Jiaxuan and Yang, Kellie and Fatokun, Omolola and Berjanskii, Mark and MacKay, Scott and Sajed, Tanvir and Han, Scott and Woudstra, Robyn and Sykes, Gina and Poelzer, Jenna and Sivakumaran, Aadhavya and Gautam, Vasuk and Wong, Gane and Wishart, David S},
title = {MarkerDB 2.0: a comprehensive molecular biomarker database for 2025},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkae1056}
}
EUVIMED